Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Angelica Tiotiu (Vandoeuvre-les-Nancy, France), Angelica Tiotiu, Yves Martinet. Gamma globulin (Ig) replacement– a potential treatment in uncontrolled asthma associated with humoral immunodeficiency (huID)?. Eur Respir J 2015; 46: Suppl. 59, 1078

Member's Comments

No comment yet.

Related content which might interest you: Evaluating omalizumab persistency of response after long-term therapy (XPORT) Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Impaired neutrophil function in patients with common variable immunodeficiency (CVID) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Total and free IgE in evolution of severe asthma after omalizumab treatment Source: International Congress 2016 – Asthma management Year: 2016 The role of maternal obesity in susceptibility to respiratory viral infection and exacerbation rate in pregnant women with asthma Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 Selective IgA deficiency and the risk of asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Cohort study of patients with asthma and immunodeficiency Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 NLRP3 inflammasome-mediated, IL-1β-dependent inflammatory responses drive steroid-resistant asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Laser acupuncture effects on serum immunoglobulin E in A topic bronchial asthma patients Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Antibody responses to rhinovirus and echovirus antigens in children with asthma exacerbations Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Identification of viral species in asthma patients with and without aspirin hypersensitivity Source: Annual Congress 2013 –Viral infections Year: 2013 Severe asthma (SA) compared to non severe persistent asthma (PA) in children: An Italian on-line database Source: International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases Year: 2014 Cytomegalovirus (CMV) modulates the immune responses against inhaled harmless antigens Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Clinical manifestations of selective IgA immunodeficiency in childhood Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 A deficient immune response to viral infections predicts asthma persistence in children Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Obese patients with partially controlled asthma: Weight control shows more benefit in IgE low patients Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 A clinically observed variability in serum total IgE in patients being considered for omalizumab therapy Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016